Background: Vulvovaginal Candidiasis (VVC) is a condition diagnosed in a large proportion of women presenting with complaints of abnormal vaginal discharge. The risk of VVC is high in women with diabetes mellitus, pregnancy, using oral contraceptives or broad-spectrum antibiotics and those having Human Immunodeficiency Virus infection.
INTRODUCTION
Candidiasis is an infection caused by yeast like fungus called, Candida. Vulvovaginal Candidiasis (VVC) refer to a disorder characterized, by signs and symptoms of vaginal inflammation in the presence of Candida species. It is characterized by curd like vaginal discharge and itching or erythema and is caused by overgrowth of Candida species in vagina. This condition is commonly known as "Vaginal yeast infection", "Vaginal Candidiasis", "Vulvovaginal Candidiasis" or "Candidal Vaginitis". 1, 2 VVC is a gynaecological condition diagnosed in a large proportion of women presenting with abnormal vaginal discharge. VVC is the most prevalent disease among females and is responsible for 10 million clinical visits every year. This disease is the second common genital tract infection among females and is usually caused by Candida albicans. Most specialists believe that 90% of cases of vaginitis are secondary to bacterial vaginosis, trichomoniasis and Vulvovaginal Candidiasis. 3, 4 The risk of VVC is high in women with diabetes mellitus, obesity, Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS), using oral contraceptives, broad spectrum antibiotics, tissue transplant, use of immunosuppressive agents and malnutrition. In pregnancy, vaginal candidiasis is common due to altered pH and sugar content in vaginal secretions, and it also has direct effect on yeast cells, causing it to grow faster and stick more easily with the walls of vagina. 3, 5 Approximately 75% of woman may have at least one episode of VVC in their lifetime, with 45% suffering from second episode and nearly half of them suffer from multiple episodes. 3 Recurrent Vulvovaginal Candidiasis (RVVC) is defined as four or more episodes of symptomatic infection within a year, with at least partial resolution of symptoms between episodes. Longitudinal DNA-typing studies suggest that, in most of the women, recurrent disease is due to vaginal endogenous reinfection with the identical strain of susceptible Candida species. 5 Candida albicans is found as the most common causative agent as it is isolated in 90% cases of VVC. Candida glabrata is usually the second most common pathogen detected in VVC followed by Candida tropicalis, Candida parapsilosis and Candida krusei. 3 Treatment of VVC is very mild, short course and consists of azole based antifungal medicine applied inside the vagina as vaginal pessary or drugs taken by mouth. One has to determine susceptibility patterns of vaginal isolates of Candida to antifungal drugs including Amphotericin B, Voriconazole, Itraconazole and Ketoconazole etc prior to commencement of treatment. If left untreated, it acts as a potential risk factor for other sexually transmitted diseases. 6, 7 Keeping the above facts in mind the present study was done to identify the various species of Candida isolated from patients with Vulvovaginal Candidiasis.
METHODS
A hospital based cross-sectional study was done over a period of 6 months from January to June 2018, among clinically suspected cases of Vulvovaginal Candidiasis attending Out Patient Department of Obstetrics and Gynaecology of Integral Institute of Medical Sciences and Research, Lucknow, to identify the various species of Candida causing VVC among these patients. The study was approved by Institutional Ethical Committee. An informed consent was taken from each female patient included in the study prior to sample collection. A predesigned questionnaire was used to get the information regarding socio-demographic profile of the enrolled patients.
Inclusion criteria
All consenting female patients of reproductive age (including pregnant women) and postmenopausal women, who presented with complaints of abnormal vaginal discharge, were included in this study.
Exclusion criteria
• Female patients below 18 years of age and those who refused to give consent were excluded from the study.
Total of 69 clinically suspected VVC cases whose High Vaginal Swabs were collected and processed in the Department of Microbiology for species identification of Candida isolates were included in the study.
Two High Vaginal Swabs (HVS) were collected from each suspected patient of VVC and processed in the Department of Microbiology. One HVS was used for direct microscopic examination by Gram's staining for presence of pus cells and Gram positive oval or round budding yeast like cells with or without pseudohyphae ( Figure 1 ). 
Statistical analysis
The collected data was analyzed using SPSS Data Editor Software version 20. Chi-square test was performed for categorical variables and p value ≤0.05 were considered statistically significant. However, this difference was not found to be statistically significant (p = 0.565). (13/14) . However, this difference of positivity among isolates from patients of urban areas as compared to those from rural patients was not found to be statistically significant (p = 0.171). 
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DISCUSSION
With the regularly changing lifestyle and dietary habits, the incidence and prevalence of Candida species infection has lowered down. Many species of Candida usually live as human commensals but it causes Candidiasis in immunocompromised persons. Several researches have shown that the infection increases during two to three last decades.
In this study out of 69 high vaginal swab samples, only 14 samples yielded positive growth for Candida species, all of them being Non-albicans Candida, thus the overall prevalence of positive VVC was 20.3%. This finding correlates with another study conducted in Bulgaria which also reported prevalence of Non-albicans Candida in VVC to be 27.4%. 9 However, in contrast to this finding of 20.3% prevalence of Candida species, a study from Yemen reported a very low prevalence of 12.7% Candida species in VVC cases. 7 In the present study amongst the Candida species isolated from VVC, Candida glabrata was the most common isolate (50%) followed by Candida tropicalis (21.43%), Candida lusitaniae (21.43%) and Candida parapsilosis (7.14%). Another study done in Puducherry, India, corroborates this finding as it reported an overall prevalence of 23.7% Candida species from 211 clinically suspected VVC cases, with Candida glabrata (45.1%) as the most common isolate, followed by Candida tropicalis (23.5%), Candida albicans (17.6%), Candida krusei (9.8%) and Candida parapsilosis (3.9%). 3 While another study from Puducherry, India, reported higher incidence of Candida tropicalis (16.4%) as compared to Candida glabrata (8%). This is in contrast to present study's finding. 10 This study reported 7.14% isolates of Candida parapsilosis among VVC cases. Another study done in Iran corroborates this finding as it reported 1% isolates of Candida parapsilosis, which is close to study. 11 In this study, author have reported 21.43% Candida lusitaniae and no isolate of Candida albicans. Another study at Puducherry, India, reported 17.6% isolates of Candida albicans and no isolate of Candida lusitaniae. 3 This is in contrast with study.
This study reported that majority of Candida isolates (23.6%) were from samples of urban patients and only 7.1% isolates were from rural patients. In contrast to this finding a study done in rural Maharashtra reported higher prevalence of VVC among them to be 35%. 12 Another study from rural Tamil Nadu reported 10% prevalence of VVC among them, this corroborates present study's finding. 13 A recent study reported that Non-albicans Candida species, particularly Candida glabrata were observed in 10-20% of women with recurrent vulvovaginal candidiasis (RVVC). 14 This is in contrast to this finding as author reported 50% isolates of Candida glabrata, but no RVVC were seen in this study.
Author reported 2.8% (2/69) positive cases of VVC patients belonging to postmenopausal age. Another study from Amritsar reported 3% of positive cases of VVC among patients belonging to postmenopausal age group. 15 This is in agreement to present study's finding.
Study reported higher incidence of VVC among patients of reproductive age group as compared to postmenopausal age group. VVC was more among patients from urban areas than those from rural areas and VVC was more among illiterate patients as compared to literate patients.
This finding hint that newer species may emerge from time to time even in VVC cases and epidemiological studies are needed to remain update about changing prevalence of Candida species.
CONCLUSION
Candidiasis is an infection caused by yeast like fungus called Candida. Vulvovaginal Candidiasis (VVC) is the most common type of vaginal infection. 75% females experience at least once in their lifetime. Candida albicans was known to be the most common causative agent of VVC. However, this study showed that all isolates from VVC were Non-albicans Candida. Therefore, this study has made it imperative that species identification should be done in all microbiology laboratories for accurate diagnosis of VVC for effective timely treatment.
